BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35567901)

  • 1. The MAP3K1/c-JUN signaling axis regulates glioblastoma stem cell invasion and tumor progression.
    Zhou S; Niu R; Sun H; Kim SH; Jin X; Yin J
    Biochem Biophys Res Commun; 2022 Jul; 612():188-195. PubMed ID: 35567901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA NEAT1 promotes malignant phenotypes and TMZ resistance in glioblastoma stem cells by regulating let-7g-5p/MAP3K1 axis.
    Bi CL; Liu JF; Zhang MY; Lan S; Yang ZY; Fang JS
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33057597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.
    Miao H; Gale NW; Guo H; Qian J; Petty A; Kaspar J; Murphy AJ; Valenzuela DM; Yancopoulos G; Hambardzumyan D; Lathia JD; Rich JN; Lee J; Wang B
    Oncogene; 2015 Jan; 34(5):558-67. PubMed ID: 24488013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
    Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
    Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
    Shin HJ; Lee S; Jung HJ
    J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
    Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
    Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
    Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.
    Kahn J; Hayman TJ; Jamal M; Rath BH; Kramp T; Camphausen K; Tofilon PJ
    Neuro Oncol; 2014 Jan; 16(1):29-37. PubMed ID: 24311635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the Phospholipase Cε-c-Jun N-Terminal Kinase Axis Suppresses Glioma Stem Cell Properties.
    Okada M; Nakagawa-Saito Y; Mitobe Y; Sugai A; Togashi K; Suzuki S; Kitanaka C
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USF1/CD90 signaling in maintaining glioblastoma stem cells and tumor-associated macrophages adhesion.
    Zhou Y; Meng X; He W; Li X; Zhao R; Dong C; Yuan D; Yang J; Zhang R; Shi G; Huang Y; Liu J; Liu J; Liu S; Fu P; Sun M
    Neuro Oncol; 2022 Sep; 24(9):1482-1493. PubMed ID: 35287174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages.
    Yuan W; Zhang Q; Gu D; Lu C; Dixit D; Gimple RC; Gao Y; Gao J; Li D; Shan D; Hu L; Li L; Li Y; Ci S; You H; Yan L; Chen K; Zhao N; Xu C; Lan J; Liu D; Zhang J; Shi Z; Wu Q; Yang K; Zhao L; Qiu Z; Lv D; Gao W; Yang H; Lin F; Wang Q; Man J; Li C; Tao W; Agnihotri S; Qian X; Mack SC; Zhang N; You Y; Rich JN; Sun G; Wang X
    Clin Cancer Res; 2023 Sep; 29(18):3779-3792. PubMed ID: 37439870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
    Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
    Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSNK1D is associated with stemness and invasiveness in glioblastoma.
    Liu Y; He W; Guo Y; Qu S; Yao F; Liu J; Chai J; Yang Y; Xu T; Liu Y; Yang D; Jia Q; Li M
    Pathol Res Pract; 2022 Dec; 240():154187. PubMed ID: 36327821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
    Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
    Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
    Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
    Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
    Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
    Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
    J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.